Inhibition of protein kinase C induces differentiation of neuroblastoma cells  by Miñana, Maria-Dolores et al.
Volume 255, number 1, 184-186 FEBS 07596 September 1989 
Inhibition of protein kinase C induces differentiation of 
neuroblastoma cells 
Mar ia -Do lores  Mi f iana ,  V icente Fe l ipo  and  Sant iago  Gr i so l ia  
Instituto de Investigaciones Citol6gicas de la Caja de Ahorros de Valencia, Centro Asociado del CSIC, Amadeo de Saboya 
4, 46010, Valencia, Spain 
Received 17 July 1989 
It is shown that 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), a specific inhibitor of protein kinase C, induces neu- 
ritogenesis inneuro 2a cells. The percentage of differentiated cells wa  9%, 20%, 59% and 85% at 0, 17, 85 and 500 ~tM 
H7, respectively. The number ofneurites/cell increased 2-, 8-and 14-fold over the controls for 17, 85 and 500 gM H7, 
respectively. These results indicate that protein kinase C play  a key role in the control f differentiation f neural cells 
and that its specific inhibition may be of basic as well as of practical importance. 
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1. INTRODUCTION 
Gangliosides are known to induce the differen- 
t iat ion of neuroblastoma cell lines with concomi- 
tant sprouting and extension of neurites [1,2], al- 
though the underlying molecular mechanism re- 
mains unknown [3,4]. Since others have shown 
that gangliosides are inhibitors of protein kinase C 
[5,6], it seemed possible that the two findings were 
related and that gangliosides might stimulate 
neuritogenesis by inhibit ing the activity of protein 
kinase C. To check this hypothesis, we have tested 
the effect of 1-(5-isoquinolinylsulfonyl)-2-methyl- 
p~perazine (H7), a specific inhibitor of protein 
kinase C [7], on neurite outgrowth of neuro 2a 
cells. We found, and show here, that H7 is a potent 
inducer of neuritogenesis, indicating a key role for 
protein kinase C in the control of  differentiation of
neural cells. 
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2. MATERIALS  AND METHODS 
2.1. Cell cultures 
The clonal line neuro 2a, C-1300 mouse neuroblastoma, was 
obtained from the American Type Culture Collection 
(Rockville, MD, USA). They were grown at 37°C in Eagle's 
minimum essential medium supplemented with 10°70 fetal 
bovine serum, 100 IU/ml penicillin and 100#g/ml strepto- 
mycin. Cells wers subcultured twice weekly. Viability was 
assessed with Trypan blue. 
2.2. Incubations with H7 
H7 (34 mM) was dissolved in dimethylsulfoxide and added 
after 24 h of subculture. The same volume f dimethylsulfoxide 
was added to the controls. Medium was ch nged and fresh H7 
was added every second day. 
2.3. Quantification of neuritogenesis 
Several randomly chosen fields of the cultures were photo- 
graphed using a phase-contrast light microscope. The number of 
neurites on each cell was counted and their lengths were 
measured. 
3. RESULTS AND DISCUSSION 
As shown in fig. 1, H7 markedly induced neurito- 
genesis in neuro 2a cells. To quanti fy neurito- 
genesis, the number  of neurites/cell  after 24 h of 
treatment with H7 was counted. As shown in table 
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Fig. 1. Effect of  H7 on neuritogenesis in neuro 2a cells. Cells were incubated for 24 h in the absence (A) or the presence of  85/zM (B) 
or 500/zM H7 (C,D) and then photographed with a phase-contrast light microscope. 
1, in controls, only 9°70 of cells are differentiated. 
The number of differentiated cells increased with 
the dose of H7 added, reaching 20%, 59°70 and 
85°70 for 17, 85 and 500/zM H7, respectively. Also, 
Table 1 
Effect of H7 on neuritogenesis in neuro 2a cells 
H7 Viability Differentiated Neurites/cell Mean 
cells length 
(aM) (%) (°70 of  total) (am) 
0 91 9 0.14 23 ___ 8 
17 88 20 0.30 58 + 14 
85 86 59 1.14 60 + 12 
500 80 85 1.90 61 + 14 
Neuro 2a cells were seeded at 200000/ml, H7 was added after 
24 h and 24 h later viability was measured and several randomly 
chosen fields were photographed. The neurites per cell were 
counted and measured in at least 200 cells per group; control 
and each concentration of H7 used 
the mean number of neurites/cell increased 
markedly with the concentration f H7, i.e. 2-, 8- 
and 14-fold higher than in controls for 17, 85 and 
500/zM H7, respectively. At all doses of H7 used, 
neurites were approximately 3 times longer than in 
controls (table 1). As shown, up to 500/zM H7 can 
be used with minimal cell toxicity; at this concen- 
tration cell viability was 80070, while for controls it 
was 91 070. 
The above results clearly demonstrate that H7, a 
specific inhibitor of protein kinase C, induces dif- 
ferentiation and euritogenesis in neuro 2a cells. 
This indicates that protein kinase C is involved in 
the control of differentiation a d neuritogenesis in 
neuro 2a cells. 
It was shown several years ago that gangliosides 
induce differentiation a d neuritogenesis in neuro- 
blastoma cells [1,2], and later that they also inhibit 
protein kinase C [5,6]. The present findings in- 
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dicate that the effect of gangliosides on differentia- 
tion is likely due to its inhibitory effect on protein 
kinase C. 
Gangliosides have been used successfully in 
animal models for the treatment of certain neuro- 
logical disorders. The following beneficial effects 
have been reported for gangliosides: timulation of 
the regeneration of the nervous ystem and facilita- 
tion of recovery after CNS damage [8], accelera- 
tion of  reinnervation [9], facilitation of learning 
performance [10], decreased mortality after induc- 
tion of global ischemia [11], counteraction of the 
slowing of nerve conduction in diabetic neuropathy 
[12], reduction of retrograde degeneration after 
neocortical lesions [13], protection against excito- 
toxin damage [14] and reduction of vincristine- 
induced neuropathy [15]. The findings reported 
here suggest hat similar effects might be obtained 
by using specific inhibitors of protein kinase C. 
In conclusion, the results we report here indicate 
that protein kinase C plays a key role in the control 
of  neural differentiation. 
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